Developing an electronic platform to monitor symptoms and generate adverse event alerts and patient feedback after discharge following upper gastrointestinal cancer surgery: eRAPID feasibility study

Abstract

Background: Surgery for upper gastrointestinal (UGI) cancer is associated with major morbidity. Some of this occurs after hospital discharge and prompt identification of serious adverse effects (AEs) is important to improve outcomes. The eRAPID feasibility study aims to develop an online questionnaire integrated within routine electronic patient records for patients to self-report AEs post-discharge. Here, we describe the system's development to generate automatic online patient self-management feedback and/or advice to contact a healthcare professional (HCP) or, for concerning symptoms, trigger HCP email alerts to contact the patient. The system's feasibility and acceptability to patients and HCPs are described.